PVH
IOBT

Psagot Value Holdings’s IO Biotech IOBT Stock Holding History

Psagot Value Holdings’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,846
Closed -$94K – 549
2022
Q4 		$94K Hold
40,846
– – 0.03% 246
2022
Q3 		$111K Buy
+40,846
New +$151K 0.03% 231

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Psagot Value Holdings's IOBT Position: Q1 2023 in Review

Psagot Value Holdings sold out of IO Biotech (IOBT) in Q1 2023, closing a stake of 40,846 shares — an estimated $94K sold.

Psagot Value Holdings first reported a position in IOBT in Q3 2022 and held it in 2 quarters. The position peaked at $111K in Q3 2022. 17 funds tracked by Wall St. Rank hold IOBT as of Q1 2023.

  • Psagot Value Holdings reported no remaining IO Biotech position as of Q1 2023 after selling out during the quarter.
  • Psagot Value Holdings sold 40,846 IO Biotech shares in Q1 2023, an estimated $94K.
  • Psagot Value Holdings first reported a position in IO Biotech in Q3 2022 and held it in 2 quarters.
  • Psagot Value Holdings's IO Biotech position peaked at $111K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held IO Biotech as of Q1 2023.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.